X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (51) 51
male (41) 41
female (40) 40
index medicus (34) 34
middle aged (34) 34
aged (28) 28
cardiac & cardiovascular systems (20) 20
adult (15) 15
medicine, general & internal (15) 15
mortality (14) 14
treatment outcome (13) 13
endocrinology & metabolism (12) 12
surgery (12) 12
double-blind method (11) 11
prospective studies (11) 11
risk factors (11) 11
abridged index medicus (10) 10
cardiovascular (10) 10
myocardial infarction (10) 10
diagnosis (9) 9
heart attacks (9) 9
risk (9) 9
analysis (8) 8
cardiovascular disease (8) 8
follow-up studies (8) 8
stroke (8) 8
acute coronary syndromes (7) 7
aspirin (7) 7
drug therapy (7) 7
medical and health sciences (7) 7
medicin och hälsovetenskap (7) 7
stents (7) 7
acute coronary syndrome (6) 6
alirocumab (6) 6
cardiac and cardiovascular systems (6) 6
cholesterol (6) 6
clinical medicine (6) 6
coronary angiography (6) 6
diabetes (6) 6
drug therapy, combination (6) 6
incidence (6) 6
kardiologi (6) 6
klinisk medicin (6) 6
patients (6) 6
physical education (6) 6
recurrence (6) 6
therapy (6) 6
cardiology (5) 5
cardiovascular diseases (5) 5
coronary vessels (5) 5
disease (5) 5
evaluation (5) 5
heart attack (5) 5
ischemia (5) 5
life sciences (5) 5
management (5) 5
myocardial infarction - drug therapy (5) 5
pcsk9 (5) 5
platelet aggregation inhibitors - adverse effects (5) 5
prevention (5) 5
time factors (5) 5
angina (4) 4
angina pectoris (4) 4
aspirin - therapeutic use (4) 4
cardiovascular diseases - mortality (4) 4
care and treatment (4) 4
cerebral infarction (4) 4
child (4) 4
classroom techniques (4) 4
cleft lip - surgery (4) 4
cleft lip and palate (4) 4
clopidogrel (4) 4
cross-sectional studies (4) 4
dentistry, oral surgery & medicine (4) 4
drug dosages (4) 4
education (4) 4
efficacy (4) 4
equipment design (4) 4
exercise (4) 4
health risk assessment (4) 4
hemorrhage - chemically induced (4) 4
human health and pathology (4) 4
hypertension (4) 4
infarction (4) 4
inpatient hyponatremia (4) 4
myocardial infarction - diagnostic imaging (4) 4
peripheral vascular disease (4) 4
platelet aggregation inhibitors - therapeutic use (4) 4
reduction (4) 4
reperfusion (4) 4
statin therapy (4) 4
statins (4) 4
studies (4) 4
ticlopidine - analogs & derivatives (4) 4
ticlopidine - therapeutic use (4) 4
trial (4) 4
unstable angina (4) 4
vasopressin (4) 4
aged, 80 and over (3) 3
angina pectoris - diagnostic imaging (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 11/2018, Volume 379, Issue 22, pp. 2097 - 2107
Among patients who had had an acute coronary syndrome, the risk of death from coronary heart disease, nonfatal myocardial infarction, stroke, or unstable... 
MEDICINE, GENERAL & INTERNAL | MANAGEMENT | MYOCARDIAL-INFARCTION | TASK-FORCE | EFFICACY | SAFETY | LDL | REDUCING LIPIDS | PCSK9 | MONOCLONAL-ANTIBODY | ASSOCIATION | Double-Blind Method | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Hypercholesterolemia - drug therapy | Anticholesteremic Agents - adverse effects | Acute Coronary Syndrome - blood | Acute Coronary Syndrome - drug therapy | Acute Coronary Syndrome - complications | Anticholesteremic Agents - therapeutic use | Proprotein Convertase 9 - antagonists & inhibitors | Cardiovascular Diseases - epidemiology | Adult | Cholesterol, LDL - blood | Female | Hypercholesterolemia - complications | Aged | Acute coronary syndrome | Diagnosis | Myocardial infarction | Fees & charges | Lipoproteins (low density) | Heart attacks | Lipids | Cardiovascular disease | Angina | Apolipoprotein B | Ischemia | Heart diseases | Drug dosages | Statins | Cerebral infarction | Stroke | Subtilisin | Angina pectoris | Patients | Low density lipoprotein | Coronary artery disease | Cholesterol | Kexin | Monoclonal antibodies | Full text | Acute coronary syndromes | Cardiovascular diseases | Health risk assessment | Pharmaceuticals | Life Sciences | Human health and pathology | Cardiology and cardiovascular system | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2017, Volume 376, Issue 18, pp. 1713 - 1722
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2015, Volume 372, Issue 19, pp. 1791 - 1800
Patients with myocardial infarction 1 to 3 years previously were assigned to ticagrelor, 90 or 60 mg twice daily, or to placebo, in addition to low-dose... 
MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | CLOPIDOGREL | MANAGEMENT | ESC GUIDELINES | AMERICAN-COLLEGE | PREVENTION | ASSOCIATION TASK-FORCE | ACUTE CORONARY SYNDROMES | PRASUGREL | ASPIRIN | Purinergic P2Y Receptor Antagonists - administration & dosage | Double-Blind Method | Drug Administration Schedule | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Risk | Secondary Prevention | Adenosine - administration & dosage | Aspirin - administration & dosage | Purinergic P2Y Receptor Antagonists - adverse effects | Myocardial Infarction - drug therapy | Adenosine - adverse effects | Adenosine - analogs & derivatives | Intracranial Hemorrhages - chemically induced | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - mortality | Female | Aged | Hemorrhage - chemically induced | Drug Therapy, Combination | Platelet Aggregation Inhibitors - adverse effects | Dose-response relationship (Biochemistry) | Treatment outcome | Care and treatment | Safety and security measures | Analysis | Dosage and administration | Ticagrelor | Heart attack | Risk factors | Myocardial infarction | Cerebral infarction | Aspirin | Stroke | Heart attacks | Hemorrhage | Long term | Patients | Thrombolysis | Bleeding | Blood platelets | Antagonist drugs | Cardiovascular diseases | Drug therapy | Life Sciences | Human health and pathology
Journal Article